We're committed to reducing the incidence of melanoma for all Australians, by creating a network of advanced 3D imaging technology systems that will improve early detection and diagnosis, particularly within regional areas.
ACRF ACEMID brings together three leading Australian universities in skin research; The University of Sydney, The University of Queensland and Monash University in Victoria.
Our goal is to integrate and leverage world-class research expertise that is unique to Australia, to provide technologically disruptive and reliable solutions for the early diagnosis of melanoma.
Together, we're creating a 3D total body skin imaging network, which will form an interconnected centre of excellence in diagnostic imaging of early melanoma.
Project update: The ACRF ACEMID project has received a wonderful response from the community to participate in our research, we have received over 3875 expressions of interest for NSW since our National Launch took place in September 2021. The ACEMID team would like to thank everyone for their willingness to contribute to this important work.
We are excited to announce the installation of the Vectra WB360 in Port Macquarie on 24 August 2023 - our first regional site in NSW!
Dermatology Department in Westmead Hospital WSLHD has commenced recruitment on 21 July 2022.
Up until the end of November 2023, all ACEMID sites have recruited a combined 5100 participants into our study and our team is working with eHealth NSW and Local Health Districts to open more sites in 2024 to build capacity for the project.
In partnership with eHealth NSW, our project will deliver teledermatology with Local Health Services, providing a connected and far-reaching early melanoma detection technology and program.
The total body 3D imaging technology at the core of ACRF ACEMID will allow for objective and secure collection of surface photography in a few milliseconds. The generated avatars enable documentation of all skin surfaces (except soles of feet, scalp and areas covered by clothing) to unprecedented levels of detail.
Sequential photography at regular intervals will allow for the detection of new or changing lesions. This detailed photography, coupled with Artificial Intelligence (being developed by the consortium) will allow the implementation of quick and cost-effective skin screening and a reduction of melanoma incidence.
The research and clinical strength underpinning the proposed ACRF ACEMID initiative include three complementary NHMRC-funded Centres of Research Excellence (CRE):
View a diagram of the ACEMID research structure (png, 289kb)
The goals of the ACRF ACEMID cohort study is to:
Melanoma Institute Australia (MIA)
The Poche Centre, 40 Rocklands Rd, Wollstonecraft NSW 2065 (opposite the Mater Hospital)
Phone: (02) 9911 7200
Western Sydney Local Health District (WSLHD) – Westmead Hospital
Department of Dermatology.
Level 2 G2- Outpatient Clinics.
Hawkesbury Road Westmead NSW 2145
Phone: (02) 8890 7149
Mid-North Coast Local Health District (MNCLHD) – Port Macquarie Community Health Centre
19-31 Morton St, Port Macquarie NSW 2444
Phone: (02) 6589 2100
Pinnacle Dermatology - Orange
272 Anson Street, Orange NSW 2800
Phone: (02) 6398 7733
Melanoma Institute Australia (Amie St Clair) – Wagga Wagga